Financing, Equity Capital Markets

Aimmune Therapeutics, Inc.

02/18
|
$202.4 Million
Piper Sandler served as bookrunner for Aimmune Therapeutics on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma